Ret and trk proto-oncogene activation in thyroid papillary carcinomas in french patients from the champagne-ardenne region
- 30 June 1996
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 29 (3), 267-271
- https://doi.org/10.1016/0009-9120(96)00006-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Oncogenes and anti-oncogenes in human epithelial thyroid tumorsJournal of Endocrinological Investigation, 1994
- Low rate of ret proto-oncogene activation (PTC/retTPC) in papillary thyroid carcinomas from saudi arabiaCancer, 1994
- Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumoursBritish Journal of Cancer, 1993
- Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A.Molecular and Cellular Biology, 1993
- Low Frequency of Rearrangements of the ret and trk Proto‐oncogenes in Japanese Thyroid Papillary CarcinomasJapanese Journal of Cancer Research, 1992
- Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.Journal of Clinical Investigation, 1992
- Lack of PTC Gene(ret Proto-oncogene Rearrangement) in Human Thyroid Tumors.Endocrinologia Japonica, 1991
- PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomasCell, 1990
- A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastasesNature, 1987
- A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequencesNature, 1986